H.U. Group Holdings (4544) Stock Overview
Operates healthcare business in Japan, the United States, Europe, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
4544 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
H.U. Group Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥3,729.00 |
| 52 Week High | JP¥3,912.00 |
| 52 Week Low | JP¥2,398.00 |
| Beta | 0.32 |
| 1 Month Change | 6.03% |
| 3 Month Change | 16.49% |
| 1 Year Change | 41.30% |
| 3 Year Change | 37.25% |
| 5 Year Change | 35.40% |
| Change since IPO | 255.14% |
Recent News & Updates
Recent updates
Returns On Capital At H.U. Group Holdings (TSE:4544) Paint A Concerning Picture
Oct 06
H.U. Group Holdings (TSE:4544) Has A Pretty Healthy Balance Sheet
Jun 12H.U. Group Holdings' (TSE:4544) Promising Earnings May Rest On Soft Foundations
May 23Revenues Not Telling The Story For H.U. Group Holdings, Inc. (TSE:4544)
May 15H.U. Group Holdings (TSE:4544) Has Affirmed Its Dividend Of ¥63.00
Mar 25Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?
Mar 10Results: H.U. Group Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 11H.U. Group Holdings (TSE:4544) Is Due To Pay A Dividend Of ¥63.00
Feb 10H.U. Group Holdings (TSE:4544) Has Affirmed Its Dividend Of ¥63.00
Dec 14Are Investors Undervaluing H.U. Group Holdings, Inc. (TSE:4544) By 38%?
Dec 13H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00
Sep 25H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00
Sep 04H.U. Group Holdings (TSE:4544) Is Due To Pay A Dividend Of ¥62.00
Aug 21Estimating The Fair Value Of H.U. Group Holdings, Inc. (TSE:4544)
Aug 20H.U. Group Holdings (TSE:4544) Is Paying Out A Dividend Of ¥62.00
Jul 26H.U. Group Holdings' (TSE:4544) Dividend Will Be ¥62.00
Jul 11Analysts Have Been Trimming Their H.U. Group Holdings, Inc. (TSE:4544) Price Target After Its Latest Report
Jun 24Does H.U. Group Holdings (TSE:4544) Have A Healthy Balance Sheet?
Jun 21H.U. Group Holdings, Inc.'s (TSE:4544) Intrinsic Value Is Potentially 54% Above Its Share Price
Feb 28Shareholder Returns
| 4544 | JP Healthcare | JP Market | |
|---|---|---|---|
| 7D | 0.8% | -0.6% | -0.8% |
| 1Y | 41.3% | -1.2% | 17.1% |
Return vs Industry: 4544 exceeded the JP Healthcare industry which returned -1.8% over the past year.
Return vs Market: 4544 exceeded the JP Market which returned 18.3% over the past year.
Price Volatility
| 4544 volatility | |
|---|---|
| 4544 Average Weekly Movement | 5.3% |
| Healthcare Industry Average Movement | 3.4% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 4544's share price has been volatile over the past 3 months compared to the JP market.
Volatility Over Time: 4544's weekly volatility (5%) has been stable over the past year, but is still higher than 75% of JP stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 5,444 | Shigekazu Takeuchi | www.hugp.com |
H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment provides general testing services to medical institutions that include esoteric testing, such as genetic and oncology testing; companion diagnostics-related tests for cancer treatment; omics analysis comprising whole genome sequencing and proteome analysis; comprehensive support for clinical trials and research, including pre-trial setup work, specimen collection and transport, measuring, result reports, and data management, as well as SaaS for general practitioners and personal health records. Its In-Vitro Diagnostics segment provides Lumipulse system products, an automated chemiluminescence enzyme immunoassay system that offers reagents; testing services for neurodegenerative diseases; and rapid diagnostics kit for infectious diseases comprising influenza and COVID-19, as well as cerebrospinal fluid reagent.
H.U. Group Holdings, Inc. Fundamentals Summary
| 4544 fundamental statistics | |
|---|---|
| Market cap | JP¥211.88b |
| Earnings (TTM) | JP¥1.39b |
| Revenue (TTM) | JP¥244.95b |
Is 4544 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4544 income statement (TTM) | |
|---|---|
| Revenue | JP¥244.95b |
| Cost of Revenue | JP¥176.23b |
| Gross Profit | JP¥68.73b |
| Other Expenses | JP¥67.34b |
| Earnings | JP¥1.39b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 11, 2025
| Earnings per share (EPS) | 24.45 |
| Gross Margin | 28.06% |
| Net Profit Margin | 0.57% |
| Debt/Equity Ratio | 53.3% |
How did 4544 perform over the long term?
See historical performance and comparisonDividends
Does 4544 pay a reliable dividends?
See 4544 dividend history and benchmarks| H.U. Group Holdings dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 12 2025 |
| Days until Ex dividend | 20 days |
| Days until Dividend pay date | 54 days |
Does 4544 pay a reliable dividends?
See 4544 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/18 21:49 |
| End of Day Share Price | 2025/10/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
H.U. Group Holdings, Inc. is covered by 12 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mitsuko Miyasako | Barclays |
| Yuki Yamazaki | Daiwa Securities Co. Ltd. |
| Tomoko Yoshihara | Daiwa Securities Co. Ltd. |